Developments in industrial chemistry and polymer science have been unleashing the ability to ward off contaminants associated with natural rubber, keeping the in-built properties pristine. Derived from the polymer via a post-emulsification technique, polyisoprene latex is stabilized with surfactant and is devoid of natural latex proteins, avoiding the risk of type 1 allergic responses for individuals suffering from an allergy to natural latex proteins. Polyisoprene latex is a vital ingredient in medical gloves, catheters, and adhesives.
Polyisoprene latex is realized by CAS Number: 9003-31-0 and is commercially available in two grades – industrial grade and medical grade. Manufacturing of consumer goods, including, industrial gloves, rubber components in DIY appliances, and auto interior parts, depends on the industrial grade. Whilst production of balloons, non-disposable gloves, and catheters bank on the medical grade. However, the manufacturing process of polyisoprene latex is subject to several health hazards. In addition, ascending environmental issues is resulting in uptightness of norms to rely on sustainable techniques, a morale-killing factor for the manufacturers.
As per the recent business intelligence report from Persistence Market Research, the polyisoprene latex market reached ~US$ 98 million in 2018 and is anticipated to accelerate at a CAGR of ~8.1% between 2019 and 2029. An uptick in construction projects in tandem with the need for enhanced aesthetics of residential as well as commercial buildings is set to promote the adoption of polyisoprene latex as industrials adhesives and paint additives. In addition, increasing consumption of consumer products is the next leg of growth for the market following anti-allergic properties.
Allergies due to Natural Rubber Creates Space for Polyisoprene Latex in Healthcare Domain
Natural latex is observing replacement with highly efficient and innovative material – polyisoprene latex. Concerns apropos allergic reactions to proteins existing in natural rubber is paving way for the employment of polyisoprene latex in surgical gloves, and condom manufacturing. Government bodies, including the FDA, persist to institute uptight policies for protection in medical gloves, and stoppers, resulting in escalating demand for polyisoprene latex owing to greater security, convenience, and purity versus legacy materials.
Manufacturers are turning to polyisoprene latex while designing tube connectors, cohesive bandages, and needle shields on grounds of rigid physical shield, and reduced possibility of leakages. Patients’ comfort top the list of the healthcare sector – a factor influencing caretakers to shift towards alternative materials, such as polychloroprene and polyisoprene, to offer anti-allergic products to the patients.
Medical Gloves and Condoms – Safe Patient Diagnosis and STD Prevention Boost the Sales of Polyisoprene Latex
Polyisoprene latex is a perfect replacement for natural rubber for medical glove production during patient diagnosis and surgical procedures in the wake of anti-allergic properties. Rising incidents of allergies due to natural rubber latex products is further amplifying the presence of polyisoprene latex.
Request For Report Sample: https://www.persistencemarketresearch.com/samples/30010
Upswing in awareness campaigns for safe intercourse and avoidance of the spreading of STDs is driving the sales of condoms, leading to increased demand for polyisoprene latex following low susceptibility to leakages, and anti-allergic aspects. Furthermore, rising awareness towards utilization of condoms in a bid to avoid unwanted pregnancies and sexually transmitting diseases among the usual demographics in developing countries of Asia, Africa, Central and Latin America tends to be one of the crucial drivers for the market of polyisoprene latex.